Quick Answer
Tanke Biosciences Corp reported Cash And Cash Equivalents At Carrying Value of $6.17 million for the year ending 2012.
- Tanke Biosciences Corp showed a decrease of -19.9% in Cash And Cash Equivalents At Carrying Value from 2011 to 2012.
- This data is from Tanke Biosciences Corp's annual report (Form 10-K), filed with the SEC on April 15, 2013.
- XBRL data for this metric is available from 2009 to 2012 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2009 to 2012), Tanke Biosciences Corp's Cash And Cash Equivalents At Carrying Value has grown by 239.3%.
- Historical annual values: Fiscal year 2012: $6.17 million | Fiscal year 2011: $7.70 million | Fiscal year 2010: $2.22 million | Fiscal year 2009: $1.82 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: